Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.

Oncology - 1 Jan 2003

Tsuda Hiroshi, Hashiguchi Yasunori, Inoue Takeshi, Yamamoto Kumio

Abstract excerpt

OBJECTIVES: In this study, we examined the alteration of the G2 pathway in endometrial hyperplasia (EH) and endometrioid-type endometrial cancer (EC), and analyzed the relationship between the G2 pathway status and the p53 pathway status. METHODS: A total of 103 cases (proliferative phase of the endometrium: 20, EH: 22, and endometrioid-type EC: 61 (I: 39, II: 5, III: 15, recurrence: 2)) were included in this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CDC2 Protein Kinase
Share to cdc25 Phosphatases
Share to Checkpoint Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin B

Share to Cyclin B1

Share to Endometrium

Share to G2 Phase

Share to Hyperplasia

Source

Identifiers

PMID: 12931023
DOI: 10.1159/000072342

Genes

ATM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.PMID 12931023Read ↗

Phenotypic features of endometrial tumors in patients with family history of cancer.Semantic proximity Read ↗

Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.Semantic proximity Read ↗

Cyclin E dysregulation and chromosomal instability in endometrial cancerSemantic proximity Read ↗

The oncogenic role of EIF4A3/CDC20 axis in the endometrial cancerSemantic proximity Read ↗

CDK13-Mediated Cell Cycle Disorder Promotes Tumorigenesis of High HMGA2 Expression Gastric CancerSemantic proximity Read ↗

Progressive derailment of cell cycle regulators in endometrial carcinogenesisSemantic proximity Read ↗

Aurora kinase A has a significant role as a therapeutic target and clinical biomarker in endometrial cancerSemantic proximity Read ↗

Relationship between p53 pathway and estrogen receptor status in endometrioid-type endometrial cancer.Semantic proximity Read ↗

Expression of tumor suppressor gene product p14ARF in endometrioid adenocarcinoma of the uterine corpus.Semantic proximity Read ↗

CYP17 genetic polymorphism in patients with endometrial hyperplasia and cancer.Semantic proximity Read ↗

Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathwaysSemantic proximity Read ↗

Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.